{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:24:34Z","timestamp":1790504674626,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T00:00:00Z","timestamp":1441152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00520-015-2903-6","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T06:42:03Z","timestamp":1441089723000},"page":"1339-1347","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3645-3960","authenticated-orcid":false,"given":"Anita R.","family":"Peoples","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W.","family":"Bushunow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila N.","family":"Garland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Heckler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Roscoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke L.","family":"Peppone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Dudgeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Kirshner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarit K.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith O.","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaker R.","family":"Dakhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie A.","family":"Flannery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary R.","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"key":"2903_CR1","first-page":"295","volume-title":"Principles and practice of supportive oncology","author":"E Bruera","year":"1998","unstructured":"Bruera E, Ripamonti C (1998) Dyspnea in patients with advanced cancer. In: Berger A, Portenoy R, Weissman D (eds) Principles and practice of supportive oncology. Lippencott-Raven Publishers, Philadelphia, pp 295\u2013308"},{"issue":"2","key":"2903_CR2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/ncponc1034","volume":"5","author":"S Booth","year":"2008","unstructured":"Booth S, Moosavi SH, Higginson IJ (2008) The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy. Nat Clin Pract Oncol 5(2):90\u2013100. doi: 10.1038\/ncponc1034","journal-title":"Nat Clin Pract Oncol"},{"key":"2903_CR3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1164\/ajrccm.159.1.ats898","volume":"159","author":"American Thoracic Society","year":"1999","unstructured":"American Thoracic Society (1999) Dyspnea: mechanisms, assessment, and management. A consensus statement. Am J Respir Crit Care Med 159:321\u2013340","journal-title":"Am J Respir Crit Care Med"},{"key":"2903_CR4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/thx.48.4.339","volume":"48","author":"MF Muers","year":"1993","unstructured":"Muers MF, Round CE (1993) Palliation of symptoms in non-small cell lung cancer: a study by the Yorkshire Regional Cancer Organisation Thoracic Group. Thorax 48:339\u2013343. doi: 10.1136\/thx.48.4.339","journal-title":"Thorax"},{"issue":"3","key":"2903_CR5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s005200100296","volume":"10","author":"C Ripamonti","year":"2002","unstructured":"Ripamonti C, Fusco F (2002) Respiratory problems in advanced cancer. Support Care Cancer 10(3):204\u2013216. doi: 10.1007\/s005200100296","journal-title":"Support Care Cancer"},{"issue":"2","key":"2903_CR6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0885-3924(00)00258-X","volume":"21","author":"D Dudgeon","year":"2001","unstructured":"Dudgeon D, Christiansen L, Sloan J, Lertzman M, Clement K (2001) Dyspnoea in cancer patients: prevalence and associated factors. J Pain Symptom Manag 21(2):95\u2013102. doi: 10.1016\/S0885-3924(00)00258-X","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"2903_CR7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1378\/chest.125.2.439","volume":"125","author":"L Sarna","year":"2004","unstructured":"Sarna L, Evangelista L, Tashkin D, Padilla G, Holmes C, Brecht ML, Grannis F (2004) Impact of respiratory symptoms and pulmonary function on quality of life of long-term survivors of non-small cell lung cancer. CHEST 125(2):439\u2013445","journal-title":"CHEST"},{"issue":"25","key":"2903_CR8","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1200\/JCO.2005.06.866","volume":"23","author":"M Maltoni","year":"2005","unstructured":"Maltoni M, Caraceni A, Brunelli C, Broeckaert B, Christakis N, Eychmueller S, Glare P, Nabal M, Vigano A, Larkin P, De Conno F, Hanks G, Kaasa S (2005) Prognostic factors in advanced cancer patients: evidence-based clinical recommendations\u2014a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol 23(25):6240\u20136248. doi: 10.1200\/JCO.2005.06.866","journal-title":"J Clin Oncol"},{"issue":"6","key":"2903_CR9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1188\/02.ONF.925-933","volume":"29","author":"R Wickham","year":"2002","unstructured":"Wickham R (2002) Dyspnea: recognizing and managing an invisible problem. Oncol Nurs Forum 29(6):925\u2013933. doi: 10.1188\/02.ONF.925-933","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"2903_CR10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0889-8588(05)70332-4","volume":"10","author":"DJ Dudgeon","year":"1996","unstructured":"Dudgeon DJ, Rosenthal S (1996) Management of dyspnea and cough in patients with cancer. Hematol Oncol Clin North Am 10(1):157\u2013171","journal-title":"Hematol Oncol Clin North Am"},{"issue":"8","key":"2903_CR11","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200605-587ST","volume":"177","author":"PN Lanken","year":"2008","unstructured":"Lanken PN, Terry PB, Delisser HM, Fahy BF, Hansen-Flaschen J, Heffner JE, Levy M, Mularski RA, Osborne ML, Prendergast TJ, Rocker G, Sibbald WJ, Wilfond B, Yankaskas JR (2008) An official American Thoracic Society clinical policy statement: palliative care for patients with respiratory diseases and critical illnesses. Am J Respir Crit Care Med 177(8):912\u2013927. doi: 10.1164\/rccm.200605-587ST 177\/8\/912","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2903_CR12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1155\/2011\/745047","volume":"18","author":"DD Marciniuk","year":"2011","unstructured":"Marciniuk DD, Goodridge D, Hernandez P, Rocker G, Balter M, Bailey P, Ford G, Bourbeau J, O\u2019Donnell DE, Maltais F, Mularski RA, Cave AJ, Mayers I, Kennedy V, Oliver TK, Brown C (2011) Managing dyspnea in patients with advanced chronic obstructive pulmonary disease: a Canadian Thoracic Society clinical practice guideline. Can Respir J 18(2):69\u201378","journal-title":"Can Respir J"},{"key":"2903_CR13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thorax.57.11.939","volume":"57","author":"AL Jennings","year":"2002","unstructured":"Jennings AL (2002) A systematic review of the use of opioids in the management of dyspnoea. Thorax 57:939\u2013944","journal-title":"Thorax"},{"issue":"2 Suppl","key":"2903_CR14","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","volume":"11","author":"R Benyamin","year":"2008","unstructured":"Benyamin R, Trescot AM, Datta S, Buenaventura R, Adlaka R, Sehgal N, Glaser SE, Vallejo R (2008) Opioid complications and side effects. Pain Physician 11(2 Suppl):S105\u2013120","journal-title":"Pain Physician"},{"issue":"2","key":"2903_CR15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.7326\/0003-4819-148-2-200801150-00010","volume":"148","author":"KA Lorenz","year":"2008","unstructured":"Lorenz KA, Lynn J, Dy SM, Shugarman LR, Wilkinson A, Mularski RA, Morton SC, Hughes RG, Hilton LK, Maglione M, Rhodes SL, Rolon C, Sun VC, Shekelle PG (2008) Evidence for improving palliative care at the end of life: a systematic review. Ann Intern Med 148(2):147\u2013159","journal-title":"Ann Intern Med"},{"issue":"10","key":"2903_CR16","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.rmed.2006.01.016","volume":"100","author":"A Neuman","year":"2006","unstructured":"Neuman A, Gunnbjornsdottir M, Tunsater A, Nystrom L, Franklin KA, Norrman E, Janson C (2006) Dyspnea in relation to symptoms of anxiety and depression: a prospective population study. Respir Med 100(10):1843\u20131849. doi: 10.1016\/j.rmed.2006.01.016","journal-title":"Respir Med"},{"key":"2903_CR17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpainsymman.2005.06.009","volume":"31","author":"AH Navigante","year":"2006","unstructured":"Navigante AH (2006) Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manag 31:38\u201347","journal-title":"J Pain Symptom Manag"},{"key":"2903_CR18","volume-title":"Dyspnoea in advanced disease: a guide to clinical management","author":"S Booth","year":"2006","unstructured":"Booth S, Dudgeon D (2006) Dyspnoea in advanced disease: a guide to clinical management, 1st edn. Oxford University Press, Oxford","edition":"1"},{"key":"2903_CR19","first-page":"CD007354","volume":"1","author":"ST Simon","year":"2010","unstructured":"Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C (2010) Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev 1:CD007354. doi: 10.1002\/14651858.CD007354.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"2903_CR20","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"J Hardman","year":"2005","unstructured":"Hardman J, Limbird L (2005) Goodman & Gilman\u2019s the pharmacological basis of therapeutics, 11th edn. McGraw-Hill, New York","edition":"11"},{"issue":"5","key":"2903_CR21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0885-3924(00)00129-9","volume":"19","author":"JP Janssens","year":"2000","unstructured":"Janssens JP, de Muralt B, Titelion V (2000) Management of dyspnea in severe chronic obstructive pulmonary disease. J Pain Symptom Manag 19(5):378\u2013392","journal-title":"J Pain Symptom Manag"},{"issue":"Suppl","key":"2903_CR22","first-page":"51","volume":"51","author":"K Rickels","year":"1990","unstructured":"Rickels K (1990) Buspirone in clinical practice. J Clin Psychiatry 51(Suppl):51\u201354","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"2903_CR23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.2165\/00003495-198632020-00002","volume":"32","author":"KL Goa","year":"1986","unstructured":"Goa KL, Ward A (1986) Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic. Drugs 32(2):114\u2013129","journal-title":"Drugs"},{"key":"2903_CR24","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"RJ Baldessarini","year":"1996","unstructured":"Baldessarini RJ (1996) Drugs and the treatment of psychiatric disorders: psychosis and anxiety. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds) Goodman & Gilman\u2019s the pharmacological basis of therapeutics. McGraw-Hill, New York"},{"issue":"3","key":"2903_CR25","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.93.3.580","volume":"93","author":"DA Mahler","year":"1988","unstructured":"Mahler DA, Wells CK (1988) Evaluation of clinical methods for rating dyspnea. CHEST 93(3):580\u2013586","journal-title":"CHEST"},{"issue":"2","key":"2903_CR26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1183\/09031936.98.12020363","volume":"12","author":"JA Wedzicha","year":"1998","unstructured":"Wedzicha JA, Bestall JC, Garrod R, Garnham R, Paul EA, Jones PW (1998) Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur Respir J 12(2):363\u2013369","journal-title":"Eur Respir J"},{"issue":"6132","key":"2903_CR27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/bmj.2.6132.241","volume":"2","author":"CR McGavin","year":"1978","unstructured":"McGavin CR, Artvinli M, Naoe H, McHardy GJ (1978) Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J 2(6132):241\u2013243","journal-title":"Br Med J"},{"key":"2903_CR28","doi-asserted-by":"crossref","unstructured":"Spielberger CD (1983) Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto. Consulting Psychologists Press, CA","DOI":"10.1037\/t06496-000"},{"issue":"3","key":"2903_CR29","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0887-6185(01)00060-3","volume":"15","author":"NS Endler","year":"2001","unstructured":"Endler NS, Kocovski NL (2001) State and trait anxiety revisited. J Anxiety Disord 15(3):231\u2013245","journal-title":"J Anxiety Disord"},{"key":"2903_CR30","doi-asserted-by":"crossref","DOI":"10.1002\/9781119013563","volume-title":"Statistical analysis with missing data","author":"RJA Little","year":"2002","unstructured":"Little RJA, Rubin DB (2002) Statistical analysis with missing data. John Wiley & Sons, Hoboken"},{"key":"2903_CR31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","volume":"16","author":"S Buuren van","year":"2007","unstructured":"van Buuren S (2007) Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 16:219\u2013242","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"2903_CR32","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1378\/chest.103.3.800","volume":"103","author":"NP Singh","year":"1993","unstructured":"Singh NP, Despars JA, Stansbury DW, Avalos K, Light RW (1993) Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. Chest 103(3):800\u2013804","journal-title":"Chest"},{"issue":"4","key":"2903_CR33","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000196202","volume":"60","author":"P Argyropoulou","year":"1993","unstructured":"Argyropoulou P, Patakas D, Koukou A, Vasiliadis P, Georgopoulos D (1993) Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration 60(4):216\u2013220","journal-title":"Respiration"},{"issue":"1","key":"2903_CR34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2165\/00023210-199707010-00007","volume":"7","author":"B Fulton","year":"1997","unstructured":"Fulton B, Brogden RN (1997) Buspirone\u2014an updated review of its clinical pharmacology and therapeutic applications. Cns Drugs 7(1):68\u201388","journal-title":"Cns Drugs"},{"issue":"17","key":"2903_CR35","first-page":"300","volume":"110","author":"B Bandelow","year":"2013","unstructured":"Bandelow B, Boerner RJ, Kasper S, Linden M, Wittchen H-W, M\u00f6ller H-J (2013) The diagnosis and treatment of generalized anxiety disorder. Dtsch Arztebl Int 110(17):300\u2013310","journal-title":"Dtsch Arztebl Int"},{"issue":"3 Suppl","key":"2903_CR36","doi-asserted-by":"crossref","first-page":"47S","DOI":"10.1097\/00004714-199006001-00010","volume":"10","author":"C Bohm","year":"1990","unstructured":"Bohm C, Robinson DS, Gammans RE, Shrotriya RC, Alms DR, Leroy A, Placchi M (1990) Buspirone therapy in anxious elderly patients: a controlled clinical trial. J Clin Psychopharmacol 10(3 Suppl):47S\u201351S","journal-title":"J Clin Psychopharmacol"},{"issue":"3 Suppl","key":"2903_CR37","doi-asserted-by":"crossref","first-page":"38S","DOI":"10.1097\/00004714-199006001-00008","volume":"10","author":"C Bohm","year":"1990","unstructured":"Bohm C, Placchi M, Stallone F, Gammans RE, Alms DR, Shrotriya RC, Robinson DS (1990) A double-blind comparison of buspirone, clobazam, and placebo in patients with anxiety treated in a general practice setting. J Clin Psychopharmacol 10(3 Suppl):38S\u201342S","journal-title":"J Clin Psychopharmacol"},{"issue":"3B","key":"2903_CR38","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0002-9343(86)90331-1","volume":"80","author":"RE Gammans","year":"1986","unstructured":"Gammans RE, Mayol RF, Labudde JA (1986) Metabolism and disposition of buspirone. Am J Med 80(3B):41\u201351. doi: 10.1016\/0002-9343(86)90331-1","journal-title":"Am J Med"},{"issue":"3","key":"2903_CR39","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0149-2918(97)80134-8","volume":"19","author":"JJ Sramek","year":"1997","unstructured":"Sramek JJ, Frackiewicz EJ, Cutler NR (1997) Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxiety. Clin Ther 19(3):498\u2013506","journal-title":"Clin Ther"},{"issue":"Suppl","key":"2903_CR40","first-page":"31","volume":"51","author":"A Petracca","year":"1990","unstructured":"Petracca A, Nisita C, McNair D, Melis G, Guerani G, Cassano GB (1990) Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone. J Clin Psychiatry 51(Suppl):31\u201339","journal-title":"J Clin Psychiatry"},{"issue":"Pt 4","key":"2903_CR41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.2044-8260.1983.tb00610.x","volume":"22","author":"RG Knight","year":"1983","unstructured":"Knight RG, Waal-Manning HJ, Spears GF (1983) Some norms and reliability data for the State-Trait Anxiety Inventory and the Zung Self-Rating Depression scale. Br J Clin Psychol 22(Pt 4):245\u2013249","journal-title":"Br J Clin Psychol"},{"issue":"3","key":"2903_CR42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0022-3999(98)00109-3","volume":"46","author":"G Addolorato","year":"1999","unstructured":"Addolorato G, Ancona C, Capristo E, Graziosetto R, Di Rienzo L, Maurizi M, Gasbarrini G (1999) State and trait anxiety in women affected by allergic and vasomotor rhinitis. J Psychosom Res 46(3):283\u2013289","journal-title":"J Psychosom Res"},{"issue":"7","key":"2903_CR43","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/gps.1330","volume":"20","author":"K Kvaal","year":"2005","unstructured":"Kvaal K, Ulstein I, Nordhus IH, Engedal K (2005) The Spielberger State-Trait Anxiety Inventory (STAI): the state scale in detecting mental disorders in geriatric patients. Int J Geriatr Psychiatry 20(7):629\u2013634. doi: 10.1002\/gps.1330","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"2903_CR44","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/2049-6958-5-3-202","volume":"5","author":"E Crisafulli","year":"2010","unstructured":"Crisafulli E, Clini EM (2010) Measures of dyspnea in pulmonary rehabilitation. Multidiscip Respir Med 5(3):202\u2013210. doi: 10.1186\/2049-6958-5-3-202","journal-title":"Multidiscip Respir Med"},{"issue":"3","key":"2903_CR45","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4103\/1817-1737.53351","volume":"4","author":"SK Chhabra","year":"2009","unstructured":"Chhabra SK, Gupta AK, Khuma MZ (2009) Evaluation of three scales of dyspnea in chronic obstructive pulmonary disease. Ann Thorac Med 4(3):128\u2013132. doi: 10.4103\/1817-1737.53351","journal-title":"Ann Thorac Med"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2903-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-015-2903-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2903-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T04:58:13Z","timestamp":1653109093000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-015-2903-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["2903"],"URL":"https:\/\/doi.org\/10.1007\/s00520-015-2903-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}